Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Phase-sensitive optical parametric amplifiers (PSOPA)

Framework: FP7 — Ideas
Programme: European Research Council
Theme: European research council
Destination: Advanced grants
Action type: Support for frontier research (ERC)
Panel: Systems and communication engineering
Countries involved: Sweden,Estonia
Call:  (ERC-2011-ADG_20110209, 2011)
Start date: 2012-03-01
End date: 2017-02-28
Duration (months): 60.0
Total project cost (EUR): 2499264.0
EU funding (EUR): 2499264.0
Participants: 2
Project status: CLOSED

Optical amplifiers are essential in optical communication systems as they compensate loss induced by the transmission fiber ensuring signal integrity of the information being transmitted, as well as in other applications such as spectroscopy. This research proposal deals with phase-sensitive optical parametric amplifiers (PSA) that have unique and superior properties compared with all other optical amplifiers, most notably the potential of noiseless amplification, very broad optical bandwidth, and being an enabler of a range of ultrafast all-optical functionalities. In communication, there is an urgent need to develop new technologies that can break the ‘nonlinear Shannon capacity limit’, which is considered a serious barrier for continued capacity increase needed to meet the exponentially growing demand for bandwidth. The use of PSAs is expected to be an essential part of this development. The objective is to unleash the unexplored potential of PSAs by generating knowledge and implementing experimental demonstrations that go substantially beyond current state-of-the-art. This involves a mix of engineering and scientific challenges with telecom and non-telecom applications in mind. We will leverage advances in other areas e.g. low loss photonic crystal fibers and highly nonlinear materials to realize compact PSAs with unprecedented performance. Specifically, we will demonstrate: • Significant merits (reach, spectral efficiency, capacity) of PSAs in optical transmission systems • High coherence, low noise lasers by utilizing ultralow noise amplifier as gain element • Very broad gain bandwidth, low noise PSAs using specially tailored nonlinear gain medium • Compact (hybrid integration compatible) PSA using new nonlinear materials • Novel ultrafast all-optical operations/signal processing using PSAs • Capability of PSAs for detection of very weak optical signals for e.g. and quantum optics

Keywords: optical amplifiers,optical communication
Development and Coordination of Synthetic Biology in the European Research Area (ERASYNBIO)

Framework: FP7 — Cooperation
Programme: Food, Agriculture and Fisheries, and Biotechnology
Destination: Life sciences, biotechnology and biochemistry for sustainable non-food products and processes
Action type: Coordination and support actions
Partnership: ERASYNBIO (ERA-NET)
Countries involved: Germany,Germany,Austria,France,Spain,Finland,Greece,Netherlands,Portugal,Slovenia,Latvia,Norway,Denmark,Switzerland,United Kingdom
Call:  (FP7-ERANET-2011-RTD, 2011)
Start date: 2012-01-01
End date: 2014-12-31
Duration (months): 36.0
Total project cost (EUR): 2350282.6
EU funding (EUR): 1997022.0
Participants: 17
Project status: CLOSED

Synthetic biology is an emerging and promising research area with the potential to have a strong impact on innovation and technological progress that is beneficial for the economy and for society as a whole. It is an area at the intersection of engineering, bioscience, chemistry, and information technology. The central idea of ERASynBio is to promote the robust development of synthetic biology by structuring and coordinating national efforts and investment. ERASynBio will develop a white paper (WP1), which will support the emergence of national synthetic biology programmes and which will lay the ground for transnational funding activities via joint calls in the project (WP6). ERASynBio will stimulate and tackle the interdisciplinary nature and immaturity by offering training and educational possibilities (WP4), establishing an interdisciplinary advisory board and inviting observers of other funding organisations. It will further provide extensive dialogue options (WP1-5) and exchange fora (WP3) for the scientific community. Close collaboration between academia and industry aiming to fertilize the innovation process will occur on several levels (WP1, WP3, WP6). To adhere to ethical, legal and societal aspects as well as to technical issues like standardisation and infrastructure development ERASynBio will trace and integrate the ongoing work and research on these framework conditions and integrate them in the white paper (WP2 and WP5). It is a challenge for the ERA-Net to successfully coordinate the newly emerging activities in this field as only a few partners have fully developed national programmes for synthetic biology. Thus it is the aim to create the ERA of synthetic biology in parallel with the development of the scientific community. It is the first time a truly European research community can be build almost from the beginning of its development.

Keywords: era-net,synthetic biology,biotechnology
International IST Postdoctoral Fellowship Programme (ISTFELLOW)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Austria
Call:  (FP7-PEOPLE-2011-COFUND, 2011)
Start date: 2012-07-01
End date: 2017-06-30
Duration (months): 60.0
Total project cost (EUR): 8521410.4
EU funding (EUR): 3408564.16
Participants: 1
Project status: CLOSED

IST Austria is a newly established, public research institution with an integrated graduate school. Founded in 2006 through an Austrian Federal Law, the IST campus in Klosterneuburg, 18 km from the center of Vienna, was opened for theoretical research in 2009 and for experimental research in 2010. The Institute is dedicated to cutting-edge basic research in the natural and mathematical sciences; it currently hosts 16 research groups - four of which are supported by ERC grants - and will grow by 5-7 new groups per year for at least the next five years. By actively promoting cross-disciplinary collaborations, IST Austria aims at breaking down the traditional boundaries between disciplines. The Institute offers an attractive, English-language environment for young scientists from all over the world and prepares them for an academic and research career. At the predoctoral level, IST Austria recruits PhD students internationally and, after a successful completion of the PhD degree, sends them abroad for their postdoctoral career. Conversely, in order to attract outstanding postdoctoral researchers from abroad, the Institute is in the process of setting up a program for outstanding international postdocs - ISTFELLOW - for 80 fellow years over 5 years plus two fellows from Austria (not part of this). ISTFELLOW will be open to qualified applicants from all over the world who are interested in spending the postdoctoral stage of their scientific research career at IST Austria. Initially, the program is intended primarily for postdocs in cell biology, evolutionary biology, neuroscience, biophysics, computer science, and related fields. As the research portfolio of the Institute will branch out into other areas in the coming years, including physics, chemistry, and mathematics, so will the ISTFELLOW program. At all times, in keeping with the spirit of the Institute, ISTFELLOW will give preference to scientists who have a strong interest in multi-disciplinary approaches.

Keywords: natural and physical sciences,cell biology and immunology,evolutionary and behavioral biology sciences,neurosciences,biophysics,software systems and game theory,computer graphics and topology
Transcriptional networks controlling lymphocyte development (LYMPHOCONTROL)

Framework: FP7 — Ideas
Programme: European Research Council
Theme: European research council
Destination: Advanced grants
Action type: Support for frontier research (ERC)
Panel: Immunity and infection
Countries involved: Austria
Call:  (ERC-2011-ADG_20110310, 2011)
Start date: 2012-07-01
End date: 2017-12-31
Duration (months): 66.0
Total project cost (EUR): 2499305.0
EU funding (EUR): 2499305.0
Participants: 1
Project status: CLOSED

Acquired immunity to foreign pathogens depends on functional B and T cells. The objective of this proposal is to elucidate the transcriptional control of lymphocyte development at three stages by deciphering the transcriptional networks specifying pro-B and pro-T cells in early lymphopoiesis and plasma cells in terminal B cell differentiation. To this end, we generated knock-in mice carrying a biotin acceptor sequence at the C-terminus of transcription factors, which can be biotinylated by transgenic co-expression of the E. coli biotin ligase BirA. In vivo biotinylation facilitates antibody-independent precipitation of these transcription factors by streptavidin pulldown (Bio-ChIP). Preliminary Bio-ChIP sequencing experiments validated this approach for genome-wide identification of transcription factor target genes. Bio-ChIP sequencing will be used to identify the target genes of key transcription factors controlling the development of pro-B cells (Ikaros, E2A, STAT5, EBF1, Pax5, PU.1, IRF4), pro-T cells (Notch1, RBP-J, GATA3, Ikaros, E2A, STAT5) and plasma cells (Blimp1, IRF4, XBP1). RNA sequencing of wild-type and mutant lymphocytes will determine the regulated target genes of these factors, which are ultimately relevant for the elucidation of transcriptional networks. The function of selected target genes at central nodes of these networks will be analyzed by the latest miR30-shRNA knockdown technology. Finally, regulatory complexes interacting with these transcription factors will be identified by streptavidin-pulldown purification and mass spectrometry followed by their integration into the transcriptional networks by ChIP-seq mapping to the transcription factor target genes. These experiments will provide fundamentally new molecular insight into the generation of all three lymphocyte stages and will contribute to a better understanding of how deregulation of the transcriptional control promotes the development of lymphoid malignancies.

Keywords: early b-cell development,early t-lymphopoiesis,plasma cell differentiation,transcriptional networks,lymphoid transcription factors,in vivo biotinylation,bio-chip sequencing,target genes
GOETHE INTERNATIONAL POSTDOC PROGRAMME (GO-IN)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Germany
Call:  (FP7-PEOPLE-2011-COFUND, 2011)
Start date: 2012-09-01
End date: 2017-08-31
Duration (months): 60.0
Total project cost (EUR): 3601620.0
EU funding (EUR): 1440648.0
Participants: 1
Project status: CLOSED

The GOETHE INTERNATIONAL POSTDOC (GO-IN) PROGRAMME will comprise 20 postdoc fellowships which will be hosted in one of seven key research areas at Goethe University. The programme focuses on incoming mobility and addresses junior researchers from all nationalities who have been awarded a doctoral degree or an equivalent qualification not earlier than four years before the start of the postdoctoral research grant being applied for. The fellowships will last 12-24 months according to the research project the fellow plans to execute at Goethe University. For the time of the fellowship the fellows will receive an employment contract according to the conditions of the labour agreement of Goethe University. This will cover social security and payments of social benefits such as a contribution to pension funds and health insurance. The programme emphasizes equal opportunities and strongly encourages the application of junior scientists who want to resume their academic career which has been interrupted because of familial reasons. The programme runs an open, merit-based competition for the applying fellows and is founded on international peer-review. Initially, the GO-IN PROGRAMME focuses on seven key research areas of the university which are selected based on their capacities and international recognition. Fellows can choose the topic and supervisor for their research project freely from these seven topics. The programme provides added value for both, the recruited postdocs and Goethe University: the postdocs will have the opportunity to gain essential international experience during a crucial stage of their career and research at Goethe University benefits from scientists at their most creative stage of their academic development.

Keywords: promotion of and career development for postdocs,health sciences,humanities,social sciences,natural sciences,physical sciences
Zukunftskolleg Incoming Fellowship Programme (ZIF-MARIE-CURIE)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Germany
Call:  (FP7-PEOPLE-2011-COFUND, 2011)
Start date: 2012-05-15
End date: 2018-05-14
Duration (months): 72.0
Total project cost (EUR): 15605856.6
EU funding (EUR): 6242342.64
Participants: 1
Project status: CLOSED

The Zukunftskolleg is an Institute of Advanced Study at the University of Konstanz, which offers postdoctoral researchers a creative space for pursuing frontier research, gaining academic independence and launching their careers at the finest research institutions in Germany and the ERA. For the continuation of the Zukunftskolleg from 2012 onwards, the fellowship format will be opened up to a larger transnational dimension. For this reason, the previous fellowship scheme ends and will be substituted by two new types of incoming fellowships: • 5-year fellowships = ZIF-MC research fellowships • 2-year fellowships = ZIF-MC postdoctoral fellowships Since these two fellowship schemes are significantly different from the previous fellowship scheme, which has ended with the last call for proposals in May 2010, the ZIF-Marie-Curie programme can be considered a completely new scheme. In addition, the Zukunftskolleg will offer 5-year fellowships that are not funded through COFUND. The main objectives of the programme are (1) to attract top-level experienced researchers from outside Germany and develop mutually-beneficial long-term research cooperations; (2) to support the career development of young postdoctoral researchers from across the world by offering a creative environment for innovative research; (3) to foster dialogue and cooperation across disciplines and generations of researchers by creating a productive and supportive community among the fellows; (4) to prepare young academics to continue their careers with the best possible curriculum and research experience; and (5) to reinforce equal opportunities for all researchers. To achieve these objectives, the Zukunftskolleg offers 48 2-year postdoctoral fellowships and 26 5-year research fellowships to excellent postdoctoral scholars who are selected on the basis of their academic track record, the quality and topicality of their research project outline, and their personal aptitude and interdisciplinary interest. During their stay at the Zukunftskolleg, they will gain academic independence and develop the disciplinary, interdisciplinary and professional skills needed to become leading experts in the international research community and decisively shape the research of the future. Thus, the Zukunftskolleg will train researchers who will advance their research fields and take up principal positions in academia and society. Fellowship-years that exceed the timeframe of the COFUND programme will be financed from the university’s own budget.

Keywords: health sciences,humanities,natural sciences,physical sciences,social sciences,technological sciences
ICIQ International Postdoctoral Mobility Programme (ICIQ-IPMP)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Spain
Call:  (FP7-PEOPLE-2011-COFUND, 2011)
Start date: 2012-05-01
End date: 2018-04-30
Duration (months): 72.0
Total project cost (EUR): 5071880.0
EU funding (EUR): 2028752.0
Participants: 1
Project status: CLOSED

The aim of the Institute of Chemical Research of Catalonia (Institut Català d’Investigació Química, ICIQ; http://www.iciq.es/ ) is to set up a training programme addressed to highly talented and motivated experienced researchers to give them the opportunity to develop their research career at the Institute. The postdoctoral researchers will have the opportunity to joint one of the research groups at the Institute, and will follow an individual research project under the supervision and mentoring of an internationally renowned group leader in a stimulating and multidisciplinary scientific environment. They will have access to the Institute scientific facilities and scientific life and will follow hands-on training activities on the use of scientific instrumentation. Coaching oriented to provide non-scientific skills of key importance for a successful scientific career, and oriented to broaden the researcher’s career development, will be a fundamental aspect of the programme. The programme will consist of 4 calls, one every year, for 11 positions for a two year post-doctoral stay. It will be actively and internationally promoted and open to worldwide researchers in an equal opportunity basis. Eligibility for the programme will require geographical mobility and other mobility experiences will be positively evaluated. The application procedure will be simple, clear and applicant friendly. The evaluation will have two stages (previous scientific achievements and research project) and the selection procedure will be based on excellence of the candidates. The Selection Committee will be composed exclusively of external members and will be chaired by an internationally recognized scientist.

Keywords: molecular science,postdoctoral programme,mobility,chemistry
GROWTH (GROWTH)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Sweden
Call:  (FP7-PEOPLE-2011-COFUND, 2011)
Start date: 2012-07-01
End date: 2018-06-30
Duration (months): 72.0
Total project cost (EUR): 24892854.0
EU funding (EUR): 9957141.6
Participants: 1
Project status: CLOSED

The long-term objective of the GROWTH project is to significantly contribute to business-academia mobility-collaborations and career development of more highly qualified future leaders with innovation skills in applied and needs-driven research at universities and colleges, SMEs, excellence centres (CoE), research institutes and large industry. VINNOVA will allocate resources for the period 2012-2017 which, in conjunction with co-financing, will result in a powerful investment comprising a total contribution exceeding € 35 million. With this programme, Mobility for Growth, VINNOVA will promote qualification and career development for people running needs-driven research within all scientific fields and which is being conducted in collaboration between academia, industry and/or the public sector. The proposed GROWTH project will add substantially to the international part and profile including its funding structure for incoming, trans-national mobility and outgoing transnational mobility with a reintegration phase of experienced researchers.

Keywords: technological sciences,health sciences,natural sciences,physical sciences
Neglected Diseases Tres Cantos Open Lab Campus (OPENLABCAMPUS)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: United Kingdom
Call:  (FP7-PEOPLE-2011-COFUND, 2011)
Start date: 2013-03-01
End date: 2019-02-28
Duration (months): 72.0
Total project cost (EUR): 2881019.73
EU funding (EUR): 1152407.89
Participants: 1
Project status: CLOSED

Scientific Area: Health, Research, Drug Discovery, Neglected diseases: Malaria, Tuberculosis and other Neglected Diseases. Beneficiary: Tres Cantos Open Lab Foundation (UK Charity). Geographical Scope: Worldwide. Duration: 5 years Continuous call with evaluations each 6 months. Researchers: 19. Maximum duration of contracts: 2 years. Mobility: Incoming. Home (sending) Institutions: High Education Institutions and Private Companies in the field of Neglected Diseases Research worldwide. Host Institution: GlaxoSmithKline Drug Discovery Unit for Diseases of the Developing World (DDW), TresCantos, Spain. The Tres Cantos Open Lab Foundation is committed to helping transform the process of drug discovery for diseases of the developing world. Our funding and support will enable researchers to work in an open environment where the wider sharing of ideas and findings will drive collaborative innovation. OpenLabCampus Cofund Program targets the selection of 19 Experienced Researchers in 5 years. Calls for proposals will be continuously open; every six months the received proposals will be evaluated and selected. Information concerning the selection timetables and procedures will be available at the Project website from the programme start and updated regularly. Candidates must obtain signed declarations of Interest by two host institutions: GSK's Diseases for Developing World (GSK-DDW) centre in Tres Cantos (Madrid, Spain) as Host Institution and a High Education Institution, Research Institution or Private Company in the Neglected Diseases Research field as Home (sending) Institution. Scientists funded by the OpenLabCampus Program will access the resources and facilities of the GlaxoSmithKline Tres Cantos Medicines Development Campus in Spain and work alongside its scientists. This programme aims to explore and test innovative open innovation and data sharing approaches which could have a later major impact in the field of Neglected Diseases and potentially provide a model for future pharmaceutical collaborative R&D worldwide.

Keywords: private public partnerships,researchers,training,biomedicine,health,tuberculosis,malaria,tripanosomiasis,neglected diseases